Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/66348
標題: 利用毛細管帶域電泳法分離及檢測傳染性華氏囊病毒顆粒
Separation and identification of infectious bursal disease virus particles by capillary zone electrophoresis
作者: 謝昕翰
Hsieh, Hsin-Han
關鍵字: capillary zone electrophoresis;毛細管帶域電泳;infectious bursal disease virus particles;傳染性華氏囊病病毒
出版社: 微生物暨公共衛生學研究所
引用: 1. 李孟修。家禽傳染性華氏囊病毒之vpx蛋白及多蛋白在昆蟲細胞中之表現、蛋白裂解與似病毒顆粒組裝之研究。碩士論文,國立中興大學,台中,2004 2. 林東如。台灣養雞場血清抗體基礎線之建立與分析。屏東科技大學,屏東,2007。 3. 蔡向榮、呂榮修。1992年台灣雞傳染性華氏囊並大流行之疫情分析。中華獸醫誌,19,249-258,1993。 4. 蔡明成。市售傳染性華氏囊病疫苗病毒株之免疫原性及其分子生物學研究。碩士論文,屏東科技大學,屏東,2002。 5. 蔡信雄。雞傳染性華氏囊炎疫苗接種計畫之探討。碩士論文,台灣大學,台北,1985。 6. 蔡倩妞。傳染性雞華氏囊病毒的vp2蛋白於大腸桿菌中組裝成次微米級似病毒顆粒之研究。碩士論文,國立中興大學,台中,2002。 7. 郁筱玲。傳染性華氏囊病毒vp2基因之核酸定序及其表現。碩士論文,國立中興大學,台中,1992。 8. 黃仁斌。雞傳染性華氏囊炎新型疫苗研究的現況與展望。專題報導,13-22,1994。 9. 黃薏澄。利用陽離子聚合物(PDADMAC)修飾開管式毛細管結合電化學偵測分析電活性陰離子之研究。碩士論文,國立中山大學,高雄,2004。 10. 何靜宜。利用桿狀病毒表現系統表現傳染性華氏囊病病毒之大片段基因。碩士論文,國立中興大學。台中,1999。 11. 朱廣中。雞傳染性華氏囊病及傳染性支氣管炎雙價疫苗之研發。碩士論文,國立中興大學。台中,2010。 12. 陳光悅。全病毒與特定抗原製備之ELISA在檢測IBDV特定抗體之比較。碩士論文,國立中興大學。台中,2010。 13. Abdel-Alim, G., Awaad, M. H., and Saif, Y. M. (2003). Characterization of Egyptian field strains of infectious bursal disease virus. Avian Dis 47(4), 1452-7. 14. Abdel-Alim, G. A., and Saif, Y. M. (2001). Immunogenicity and antigenicity of very virulent strains of infectious bursal disease viruses. Avian Dis 45(1), 92-101. 15. Allan, G. M., McNulty, M. S., Connor, T. J., McCracken, R. M., and McFerran, J. B. (1984). Rapid diagnosis of infectious bursal disease infection by immunofluorescence on clinical material. Avian Pathol 13(3), 419-27. 16. Anderson, M. D., Breidinger, S. A., and Woolf, E. J. (2009). Effect of disease state on ionization during bioanalysis of MK-7009, a selective HCV NS3/NS4 protease inhibitor, in human plasma and human Tween-treated urine by high-performance liquid chromatography with tandem mass spectrometric detection. J Chromatogr B Analyt Technol Biomed Life Sci 877(11-12), 1047-56. 17. Azad, A. A., Barrett, S. A., and Fahey, K. J. (1985). The characterization and molecular cloning of the double-stranded RNA genome of an Australian strain of infectious bursal disease virus. Virology 143(1), 35-44. 18. Azad, A. A., Fahey, K. J., Barrett, S. A., Erny, K. M., and Hudson, P. J. (1986). Expression in Escherichia coli of cDNA fragments encoding the gene for the host-protective antigen of infectious bursal disease virus. Virology 149(2), 190-8. 19. Azad, A. A., Jagadish, M. N., Brown, M. A., and Hudson, P. J. (1987). Deletion mapping and expression in Escherichia coli of the large genomic segment of a birnavirus. Virology 161(1), 145-52. 20. Barackman, J., Prado, I., Karunatilake, C., and Furuya, K. (2004). Evaluation of on-line high-performance size-exclusion chromatography, differential refractometry, and multi-angle laser light scattering analysis for the monitoring of the oligomeric state of human immunodeficiency virus vaccine protein antigen. J Chromatogr A 1043(1), 57-64. 21. Bayliss, C. D., Peters, R. W., Cook, J. K., Reece, R. L., Howes, K., Binns, M. M., and Boursnell, M. E. (1991). A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus. Arch Virol 120(3-4), 193-205. 22. Bayliss, C. D., Spies, U., Shaw, K., Peters, R. W., Papageorgiou, A., Muller, H., and Boursnell, M. E. (1990). A comparison of the sequences of segment A of four infectious bursal disease virus strains and identification of a variable region in VP2. J Gen Virol 71 ( Pt 6), 1303-12. 23. Becht, H., Muller, H., and Muller, H. K. (1988). Comparative studies on structural and antigenic properties of two serotypes of infectious bursal disease virus. J Gen Virol 69 ( Pt 3), 631-40. 24. Bentley, W. E., Wang, M. Y., and Vakharia, V. (1994). Development of an efficient bioprocess for poultry vaccines using high-density insect cell culture. Ann N Y Acad Sci 745, 336-59. 25. Benton, W. J., Cover, M. S., Rosenberger, J. K., and Lake, R. S. (1967). Physicochemical properties of the infectious bursal agent (IBA). Avian Dis 11(3), 438-45. 26. Berg, T. P., Gonze, M., and Meulemans, G. (1991). Acute infectious bursal disease in poultry: Isolation and characterisation of a highly virulent strain. Avian Pathol 20(1), 133-43. 27. Birghan, C., Mundt, E., and Gorbalenya, A. E. (2000). A non-canonical lon proteinase lacking the ATPase domain employs the ser-Lys catalytic dyad to exercise broad control over the life cycle of a double-stranded RNA virus. EMBO J 19(1), 114-23. 28. Blanche, F., Cameron, B., Barbot, A., Ferrero, L., Guillemin, T., Guyot, S., Somarriba, S., and Bisch, D. (2000). An improved anion-exchange HPLC method for the detection and purification of adenoviral particles. Gene Ther 7(12), 1055-62. 29. Bottcher, B., Kiselev, N. A., Stel''Mashchuk, V. Y., Perevozchikova, N. A., Borisov, A. V., and Crowther, R. A. (1997). Three-dimensional structure of infectious bursal disease virus determined by electron cryomicroscopy. J Virol 71(1), 325-30. 30. Brandt, M., Yao, K., Liu, M., Heckert, R. A., and Vakharia, V. N. (2001). Molecular determinants of virulence, cell tropism, and pathogenic phenotype of infectious bursal disease virus. J Virol 75(24), 11974-82. 31. Brown, M. D., Green, P., and Skinner, M. A. (1994). VP2 sequences of recent European ''very virulent'' isolates of infectious bursal disease virus are closely related to each other but are distinct from those of ''classical'' strains. J Gen Virol 75 ( Pt 3), 675-80. 32. Bumstead, N., Reece, R. L., and Cook, J. K. (1993). Genetic differences in susceptibility of chicken lines to infection with infectious bursal disease virus. Poult Sci 72(3), 403-10. 33. Burkhardt, E., and Muller, H. (1987). Susceptibility of chicken blood lymphoblasts and monocytes to infectious bursal disease virus (IBDV). Arch Virol 94(3-4), 297-303. 34. Caston, J. R., Martinez-Torrecuadrada, J. L., Maraver, A., Lombardo, E., Rodriguez, J. F., Casal, J. I., and Carrascosa, J. L. (2001). C terminus of infectious bursal disease virus major capsid protein VP2 is involved in definition of the T number for capsid assembly. J Virol 75(22), 10815-28. 35. Castro-Acosta, R. M., Revilla, A. L., Ramirez, O. T., and Palomares, L. A. (2010). Separation and quantification of double- and triple-layered rotavirus-like particles by CZE. Electrophoresis 31(8), 1376-81. 36. Cereghino, G. P., Cereghino, J. L., Ilgen, C., and Cregg, J. M. (2002). Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris. Curr Opin Biotechnol 13(4), 329-32. 37. Cereghino, J. L., and Cregg, J. M. (2000). Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol Rev 24(1), 45-66. 38. Chahal, P. S., Transfiguracion, J., Bernier, A., Voyer, R., Coffey, M., and Kamen, A. (2007). Validation of a high-performance liquid chromatographic assay for the quantification of Reovirus particles type 3. J Pharm Biomed Anal 45(3), 417-21. 39. Che, J., Meng, Q., Chen, Z., Hou, Y., Shan, C., and Cheng, Y. (2010). Quantitative analysis of a novel HIV fusion inhibitor (sifuvirtide) in HIV infected human plasma using high-performance liquid chromatography-electrospray ionization tandem mass spectrometry. J Pharm Biomed Anal 51(4), 927-33. 40. Chen, F. T., Liu, C. M., Hsieh, Y. Z., and Sternberg, J. C. (1991). Capillary electrophoresis--a new clinical tool. Clin Chem 37(1), 14-9. 41. Cheng, Y. S., Lee, M. S., Lai, S. Y., Doong, S. R., and Wang, M. Y. (2001). Separation of pure and immunoreactive virus-like particles using gel filtration chromatography following immobilized metal ion affinity chromatography. Biotechnol Prog 17(2), 318-25. 42. Chettle, N., Stuart, J. C., and Wyeth, P. J. (1989). Outbreak of virulent infectious bursal disease in East Anglia. Vet Rec 125(10), 271-2. 43. Chevalier, C., Lepault, J., Erk, I., Da Costa, B., and Delmas, B. (2002). The maturation process of pVP2 requires assembly of infectious bursal disease virus capsids. J Virol 76(5), 2384-92. 44. Clarke, D., Griffin, S., Beales, L., Gelais, C. S., Burgess, S., Harris, M., and Rowlands, D. (2006). Evidence for the formation of a heptameric ion channel complex by the hepatitis C virus p7 protein in vitro. J Biol Chem 281(48), 37057-68. 45. Cooper, B., Eckert, D., Andon, N. L., Yates, J. R., and Haynes, P. A. (2003). Investigative proteomics: identification of an unknown plant virus from infected plants using mass spectrometry. J Am Soc Mass Spectrom 14(7), 736-41. 46. Corradini, D. (1997). Buffer additives other than the surfactant sodium dodecyl sulfate for protein separations by capillary electrophoresis. J Chromatogr B Biomed Sci Appl 699(1-2), 221-56. 47. Cosgrove, A. S. (1962). An apparently new disease of chickens: avian nephrosis. Avian Dis 6, 385-389. 48. Cotton, F., Lin, C., Fontaine, B., Gulbis, B., Janssens, J., and Vertongen, F. (1999). Evaluation of a capillary electrophoresis method for routine determination of hemoglobins A2 and F. Clin Chem 45(2), 237-43. 49. Cruz-Coy, J. S., Giambrone, J. J., and Panangala, V. S. (1993). Production and characterization of monoclonal antibodies against variant A infectious bursal disease virus. Avian Dis 37(2), 406-11. 50. Dalluge, J. J., and Sander, L. C. (1998). Precolumn affinity capillary electrophoresis for the identification of clinically relevant proteins in human serum: application to human cardiac troponin I. Anal Chem 70(24), 5339-43. 51. Decroly, E., Imbert, I., Coutard, B., Bouvet, M., Selisko, B., Alvarez, K., Gorbalenya, A. E., Snijder, E. J., and Canard, B. (2008). Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2''O)-methyltransferase activity. J Virol 82(16), 8071-84. 52. Desai, M. J., and Armstrong, D. W. (2003). Separation, identification, and characterization of microorganisms by capillary electrophoresis. Microbiol Mol Biol Rev 67(1), 38-51, table of contents. 53. Dobos, P., Hill, B. J., Hallett, R., Kells, D. T., Becht, H., and Teninges, D. (1979). Biophysical and biochemical characterization of five animal viruses with bisegmented double-stranded RNA genomes. J Virol 32(2), 593-605. 54. Eglon, M. N., Duffy, A. M., O''Brien, T., and Strappe, P. M. (2009). Purification of adenoviral vectors by combined anion exchange and gel filtration chromatography. J Gene Med 11(11), 978-89. 55. Engelardt, W. B., T Schmitt, (1996). CAPILLARY ELECTROPHORESIS METHODS AND POTENTIALS,. Braunshweig, Vieweg,, 5. 56. Fahey, K. J., Erny, K., and Crooks, J. (1989). A conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens. J Gen Virol 70 ( Pt 6), 1473-81. 57. Fahey, K. J., McWaters, P., Brown, M. A., Erny, K., Murphy, V. J., and Hewish, D. R. (1991). Virus-neutralizing and passively protective monoclonal antibodies to infectious bursal disease virus of chickens. Avian Dis 35(2), 365-73. 58. Fahey, K. J., O''Donnell, I. J., and Azad, A. A. (1985). Characterization by Western blotting of the immunogens of infectious bursal disease virus. J Gen Virol 66 ( Pt 7), 1479-88. 59. Faragher, J. T., Allan, W. H., and Cullen, G. A. (1972). Immunosuppressive effect of the infectious bursal agent in the chicken. Nat New Biol 237(73), 118-9. 60. Fernandez-Arias, A., Risco, C., Martinez, S., Albar, J. P., and Rodriguez, J. F. (1998). Expression of ORF A1 of infectious bursal disease virus results in the formation of virus-like particles. J Gen Virol 79 ( Pt 5), 1047-54. 61. Fernandez, A., Martin de las Mulas, J., Sierra, M. A., Carranza, J., and Jover, A. (1989). Immunohistological identification of both infectious bursal and Marek virus antigens in the bursa of Fabricius. Dtsch Tierarztl Wochenschr 96(4), 192-4. 62. Firth, G. A. (1974). Letter: Occurrence of an infectious bursal syndrome within an Australian poultry flock. Aust Vet J 50(3), 128-30. 63. Gao, H., Wang, J., Zhang, W., Jiang, Y., Niu, D., and Wang, X. (2003). [Recombinant adenovirus carrying glial cell line-derived neurotrophic factor gene protect midbrain dopaminergic neurons in mice]. Beijing Da Xue Xue Bao 35(3), 256-60. 64. Grimshaw, J., Trocha-Grimshaw, J., Fisher, W., Rice, A., Smith, S., Spedding, P., Duffy, J., and Mollan, R. (1996). Quantitative analysis of hyaluronan in human synovial fluid using capillary electrophoresis. Electrophoresis 17(2), 396-400. 65. Guittet, M., Le Coq, H., Picault, J. P., Eterradossi, N., and Bennejean, G. (1992). Safety of infectious bursal disease vaccines: assessment of an acceptability threshold. Dev Biol Stand 79, 147-52. 66. Hassett, D. E., Zhang, J., and Whitton, J. L. (1997). Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge. J Virol 71(10), 7881-8. 67. Heine, H. G., Haritou, M., Failla, P., Fahey, K., and Azad, A. (1991). Sequence analysis and expression of the host-protective immunogen VP2 of a variant strain of infectious bursal disease virus which can circumvent vaccination with standard type I strains. J Gen Virol 72 ( Pt 8), 1835-43. 68. Hempe, J. M., and Craver, R. D. (1994). Quantification of hemoglobin variants by capillary isoelectric focusing. Clin Chem 40(12), 2288-95. 69. Hirai, K., and Calnek, B. W. (1979). In vitro replication of infectious bursal disease virus in established lymphoid cell lines and chicken B lymphocytes. Infect Immun 25(3), 964-70. 70. Hirai, K., and Shimakura, S. (1974). Structure of infectious bursal disease virus. J Virol 14(4), 957-64. 71. Hirai, K., Shimakura, S., and Kawamoto, E. (1974). Electron-microscope characterization of infectious bursal disease virus. Avian Dis 18(3), 467-71. 72. Hjerten, S. (1967). Free zone electrophoresis. Chromatogr Rev 9(2), 122-219. 73. Holmes, R. P. (1995). Measurement of urinary oxalate and citrate by capillary electrophoresis and indirect ultraviolet absorbance. Clin Chem 41(9), 1297-301. 74. Inoue, M., Fujita, A., and Maeda, K. (1999). Lysis of myelocytes in chickens infected with infectious bursal disease virus. Vet Pathol 36(2), 146-51. 75. Inoue, M., Yamamoto, H., Matuo, K., and Hihara, H. (1992). Susceptibility of chicken monocytic cell lines to infectious bursal disease virus. J Vet Med Sci 54(3), 575-7. 76. J. Zhou, L., Chew, & Wang (1982). Isolation of the infectious bursal disease agent of chickens in the Beijing area. China Journal of Veterinary Medicine 8, 25-26. 77. Jackwood, D. H., and Saif, Y. M. (1987). Antigenic diversity of infectious bursal disease viruses. Avian Dis 31(4), 766-70. 78. Jackwood, D. J. (1990). Development and characterization of nucleic acid probes to infectious bursal disease viruses. Vet Microbiol 24(3-4), 253-60. 79. Jackwood, D. J., Saif, Y. M., and Moorhead, P. D. (1985). Immunogenicity and antigenicity of infectious bursal disease virus serotypes I and II in chickens. Avian Dis 29(4), 1184-94. 80. Jackwood, D. J., and Sommer, S. E. (1999). Restriction fragment length polymorphisms in the VP2 gene of infectious bursal disease viruses from outside the United States. Avian Dis 43(2), 310-4. 81. Jackwood, M. W., Yousef, N. M., and Hilt, D. A. (1997). Further development and use of a molecular serotype identification test for infectious bronchitis virus. Avian Dis 41(1), 105-10. 82. Jagadish, M. N., Laughton, D. L., Azad, A. A., and Macreadie, I. G. (1991). Stable synthesis of viral protein 2 of infectious bursal disease virus in Saccharomyces cerevisiae. Gene 108(2), 275-9. 83. Jagadish, M. N., Staton, V. J., Hudson, P. J., and Azad, A. A. (1988). Birnavirus precursor polyprotein is processed in Escherichia coli by its own virus-encoded polypeptide. J Virol 62(3), 1084-7. 84. Jandik, G. B. (1993). CAPILLARY ELECTROPHORESIS OF SMALL MOLECULES AND IONS,. VCH Publishers, Inc., New York,, 25. 85. Jin, W., Dong, Q., Yu, D., and Ye, X. (2000). Monitoring myoglobin by capillary zone electrophoresis with end-column amperometric detection. Electrophoresis 21(8), 1535-9. 86. Jorgenson, J. W., and Lukacs, K. D. (1981). Free-zone electrophoresis in glass capillaries. Clin Chem 27(9), 1551-3. 87. Kaufer, I., and Weiss, E. (1976). Electron-microscope studies on the pathogenesis of infectious bursal disease after intrabursal application of the causal virus. Avian Dis 20(3), 483-95. 88. Kim, I. J., Karaca, K., Pertile, T. L., Erickson, S. A., and Sharma, J. M. (1998). Enhanced expression of cytokine genes in spleen macrophages during acute infection with infectious bursal disease virus in chickens. Vet Immunol Immunopathol 61(2-4), 331-41. 89. Klinman, D. M., Takeno, M., Ichino, M., Gu, M., Yamshchikov, G., Mor, G., and Conover, J. (1997). DNA vaccines: safety and efficacy issues. Springer Semin Immunopathol 19(2), 245-56. 90. Kochan, G., Gonzalez, D., and Rodriguez, J. F. (2003). Characterization of the RNA-binding activity of VP3, a major structural protein of Infectious bursal disease virus. Arch Virol 148(4), 723-44. 91. Kok, Y. Y., Chu, W. L., Phang, S. M., Mohamed, S. M., Naidu, R., Lai, P. J., Ling, S. N., Mak, J. W., Lim, P. K., Balraj, P., and Khoo, A. S. (2011). Inhibitory activities of microalgal extracts against Epstein-Barr virus DNA release from lymphoblastoid cells. J Zhejiang Univ Sci B 12(5), 335-45. 92. Kremser, L., Bilek, G., Blaas, D., and Kenndler, E. (2007). Capillary electrophoresis of viruses, subviral particles and virus complexes. J Sep Sci 30(11), 1704-13. 93. Krylova, S. M., Rozenberg, D., Coulton, J. W., and Krylov, S. N. (2004). Monitoring viral DNA release with capillary electrophoresis. Analyst 129(12), 1234-7. 94. Kuhn, I., Larsen, B., Gross, C., and Hermiston, T. (2007). High-performance liquid chromatography method for rapid assessment of viral particle number in crude adenoviral lysates of mixed serotype. Gene Ther 14(2), 180-4. 95. Lee, C. C., Ko, T. P., Lee, M. S., Chou, C. C., Lai, S. Y., Wang, A. H., and Wang, M. Y. (2003). Purification, crystallization and preliminary X-ray analysis of immunogenic virus-like particles formed by infectious bursal disease virus (IBDV) structural protein VP2. Acta Crystallogr D Biol Crystallogr 59(Pt 7), 1234-7. 96. Lee, L. H., Ting, L. J., Shien, J. H., and Shieh, H. K. (1994). Single-tube, noninterrupted reverse transcription-PCR for detection of infectious bursal disease virus. J Clin Microbiol 32(5), 1268-72. 97. Leff, R. L., Miller, F. W., Hicks, J., Fraser, D. D., and Plotz, P. H. (1993). The treatment of inclusion body myositis: a retrospective review and a randomized, prospective trial of immunosuppressive therapy. Medicine (Baltimore) 72(4), 225-35. 98. Lejal, N., Da Costa, B., Huet, J. C., and Delmas, B. (2000). Role of Ser-652 and Lys-692 in the protease activity of infectious bursal disease virus VP4 and identification of its substrate cleavage sites. J Gen Virol 81(Pt 4), 983-92. 99. Liang, S., and Schneider, R. J. (2009). Capillary zone electrophoresis of Cowpea mosaic virus and peak identification. Electrophoresis 30(9), 1572-8. 100. Liu, a. T. (2001). Quantitative analysis of parasporal crystal protein from bacillus thuringiensis by capillary electrophoresis. Journal of Food and Drug Analysis, 9, 79-83. 101. Lokkegaard, T., Nielsen, J. E., Hasholt, L., Fenger, K., Werdelin, L., Tranebjaerg, L., Lauritzen, M., Colding-Jorgensen, E., Gronbech-Jensen, M., Henriksen, O. A., and Sorensen, S. A. (1998). Machado-Joseph disease in three Scandinavian families. J Neurol Sci 156(2), 152-7. 102. Lombardo, E., Maraver, A., Caston, J. R., Rivera, J., Fernandez-Arias, A., Serrano, A., Carrascosa, J. L., and Rodriguez, J. F. (1999). VP1, the putative RNA-dependent RNA polymerase of infectious bursal disease virus, forms complexes with the capsid protein VP3, leading to efficient encapsidation into virus-like particles. J Virol 73(8), 6973-83. 103. LUKERT, P. D. S., Y. M. (2003). IInfectious bursal disease. In Diseases of Poultry. 11th edn. Ed Y. M. Saif.Ames, Iowa State University Press., 161-179. 104. Macreadie, I. G., and Azad, A. A. (1991). Internal initiation and frameshifting in infectious bursal disease virus sequence expressed in Escherichia coli. Virology 184(2), 773-6. 105. Macreadie, I. G., Vaughan, P. R., Chapman, A. J., McKern, N. M., Jagadish, M. N., Heine, H. G., Ward, C. W., Fahey, K. J., and Azad, A. A. (1990). Passive protection against infectious bursal disease virus by viral VP2 expressed in yeast. Vaccine 8(6), 549-52. 106. Manickan, E., Kanangat, S., Rouse, R. J., Yu, Z., and Rouse, B. T. (1997). Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J Leukoc Biol 61(2), 125-32. 107. Mann, B., Traina, J. A., Soderblom, C., Murakami, P. K., Lehmberg, E., Lee, D., Irving, J., Nestaas, E., and Pungor, E. (2000). Capillary zone electrophoresis of a recombinant adenovirus. J Chromatogr A 895(1-2), 329-37. 108. Maraver, A., Clemente, R., Rodriguez, J. F., and Lombardo, E. (2003a). Identification and molecular characterization of the RNA polymerase-binding motif of infectious bursal disease virus inner capsid protein VP3. J Virol 77(4), 2459-68. 109. Maraver, A., Ona, A., Abaitua, F., Gonzalez, D., Clemente, R., Ruiz-Diaz, J. A., Caston, J. R., Pazos, F., and Rodriguez, J. F. (2003b). The oligomerization domain of VP3, the scaffolding protein of infectious bursal disease virus, plays a critical role in capsid assembly. J Virol 77(11), 6438-49. 110. Margraf, R. L., Erali, M., Liew, M., and Wittwer, C. T. (2004). Genotyping hepatitis C virus by heteroduplex mobility analysis using temperature gradient capillary electrophoresis. J Clin Microbiol 42(10), 4545-51. 111. Mario, N., Baudin, B., Bruneel, A., Janssens, J., and Vaubourdolle, M. (1999). Capillary zone electrophoresis for the diagnosis of congenital hemoglobinopathies. Clin Chem 45(2), 285-8. 112. Mathis, P. K., Ciarlet, M., Campbell, K. M., Wang, S., Owen, K. E., and Ranheim, T. S. (2010). Separation of rotavirus double-layered particles and triple-layered particles by capillary zone electrophoresis. J Virol Methods 169(1), 13-21. 113. McFerran, J. B., McNulty, M. S., McKillop, E. R., Connor, T. J., McCracken, R. M., Collins, D. S., and Allan, G. M. (1980). Isolation and serological studies with infectious bursal disease viruses from fowl, turkeys and ducks: demonstration of a second serotype. Avian Pathol 9(3), 395-404. 114. Meador, C. B., Middlebrooks, R. L., and Martin, B. J. (1984). Serological alterations in carcinogen-exposed teleosts: procedures for preparation and analysis of samples from small fish. Natl Cancer Inst Monogr 65, 211-6. 115. Mikkers, F., Ringoir, S., and De Smet, R. (1979). Analytical isotachophoresis of uremic blood samples. J Chromatogr 162(3), 341-50. 116. Moir, D. T., and Dumais, D. R. (1987). Glycosylation and secretion of human alpha-1-antitrypsin by yeast. Gene 56(2-3), 209-17. 117. Morgan, M. M., Macreadie, I. G., Harley, V. R., Hudson, P. J., and Azad, A. A. (1988). Sequence of the small double-stranded RNA genomic segment of infectious bursal disease virus and its deduced 90-kDa product. Virology 163(1), 240-2. 118. Muller, H. (1986). Replication of infectious bursal disease virus in lymphoid cells. Arch Virol 87(3-4), 191-203. 119. Muller, H., and Becht, H. (1982). Biosynthesis of virus-specific proteins in cells infected with infectious bursal disease virus and their significance as structural elements for infectious virus and incomplete particles. J Virol 44(1), 384-92. 120. Muller, H., Islam, M. R., and Raue, R. (2003). Research on infectious bursal disease--the past, the present and the future. Vet Microbiol 97(1-2), 153-65. 121. Muller, H., Lange, H., and Becht, H. (1986). Formation, characterization and interfering capacity of a small plaque mutant and of incomplete virus particles of infectious bursal disease virus. Virus Res 4(3), 297-309. 122. Muller, H., Scholtissek, C., and Becht, H. (1979). The genome of infectious bursal disease virus consists of two segments of double-stranded RNA. J Virol 31(3), 584-9. 123. Mundt, E., Beyer, J., and Muller, H. (1995). Identification of a novel viral protein in infectious bursal disease virus-infected cells. J Gen Virol 76 ( Pt 2), 437-43. 124. Mundt, E., Kollner, B., and Kretzschmar, D. (1997). VP5 of infectious bursal disease virus is not essential for viral replication in cell culture. J Virol 71(7), 5647-51. 125. Mundt, J., and Lusch, R. F. (1997). Informal and formal care for the elderly: decision determinants and their implications. Health Mark Q 14(3), 53-68. 126. Nagabayashi, T., Izawa, H., and Soekawa, M. (1973). Infectious bursal disease viral particles revealed in avian cell culture by electron microscope. Kitasato Arch Exp Med 46(3-4), 135-7. 127. Nick, H., Cursiefen, D., and Becht, H. (1976). Structural and growth characteristics of infectious bursal disease virus. J Virol 18(1), 227-34. 128. Okun, V. M., Ronacher, B., Blaas, D., and Kenndler, E. (1999). Analysis of common cold virus (human rhinovirus serotype 2) by capillary zone electrophoresis: the problem of peak identification. Anal Chem 71(10), 2028-32. 129. Onunkwo, O., and Momoh, M. A. (1981). [Laboratory diagnosis of infectious bursal disease (IBD) in northern Nigeria (1975-1979)]. Bull Anim Health Prod Afr 29(3), 243-9. 130. Ozel, M., and Gelderblom, H. (1985). Capsid symmetry of viruses of the proposed Birnavirus group. Arch Virol 84(3-4), 149-61. 131. Pertmer, T. M., and Robinson, H. L. (1999). Studies on antibody responses following neonatal immunization with influenza hemagglutinin DNA or protein. Virology 257(2), 406-14. 132. Petek, M., D''Aprile, P. N., and Cancellotti, F. (1973). Biological and physico-chemical properties of the infectious bursal disease virus (IBDV). Avian Pathol 2(2), 135-52. 133. Pitcovski, J., Di-Castro, D., Shaaltiel, Y., Azriel, A., Gutter, B., Yarkoni, E., Michael, A., Krispel, S., and Levi, B. Z. (1996). Insect cell-derived VP2 of infectious bursal disease virus confers protection against the disease in chickens. Avian Dis 40(4), 753-61. 134. Pitcovski, J., Levi, B. Z., Maray, T., Di-Castro, D., Safadi, A., Krispel, S., Azriel, A., Gutter, B., and Michael, A. (1999). Failure of viral protein 3 of infectious bursal disease virus produced in prokaryotic and eukaryotic expression systems to protect chickens against the disease. Avian Dis 43(1), 8-15. 135. Qin, L., Qi, X., Gao, H., Gao, Y., Bu, Z., and Wang, X. (2009). Exchange of the VP5 of infectious bursal disease virus in a serotype I strain with that of a serotype II strain reduced the viral replication and cytotoxicity. J Microbiol 47(3), 344-50. 136. Rautenschlein, S., Yeh, H. Y., and Sharma, J. M. (2003). Comparative immunopathogenesis of mild, intermediate, and virulent strains of classic infectious bursal disease virus. Avian Dis 47(1), 66-78. 137. Rodenberg, J., Sharma, J. M., Belzer, S. W., Nordgren, R. M., and Naqi, S. (1994). Flow cytometric analysis of B cell and T cell subpopulations in specific-pathogen-free chickens infected with infectious bursal disease virus. Avian Dis 38(1), 16-21. 138. Saif, L. a. (2003). Infectious bursal disease. In Diseases of Poultry. 11th edn. Ed Y. M. Saif.Ames, Iowa State University Press., 161-179. 139. Sapats, S. I., and Ignjatovic, J. (2000). Antigenic and sequence heterogeneity of infectious bursal disease virus strains isolated in Australia. Arch Virol 145(4), 773-85. 140. Schmerr, M. J., and Goodwin, K. R. (1993). Characterization by capillary electrophoresis of the surface glycoproteins of ovine lentiviruses before and after treatment with glycosidic enzymes. J Chromatogr A 652(1), 199-205. 141. Schmitz, G., Mollers, C., and Richter, V. (1997). Analytical capillary isotachophoresis of human serum lipoproteins. Electrophoresis 18(10), 1807-13. 142. Sharma, J. M., Kim, I. J., Rautenschlein, S., and Yeh, H. Y. (2000). Infectious bursal disease virus of chickens: pathogenesis and immunosuppression. Dev Comp Immunol 24(2-3), 223-35. 143. Shieh, L. (1983). Infectious bursal Disease in Taiwan. Journal of the Chinese Society of Veterinary Science 9, 61-65. 144. Smith, G. E., Summers, M. D., and Fraser, M. J. (1983). Production of human beta interferon in insect cells infected with a baculovirus expression vector. Mol Cell Biol 3(12), 2156-65. 145. Spies, U., and Muller, H. (1990). Demonstration of enzyme activities required for cap structure formation in infectious bursal disease virus, a member of the birnavirus group. J Gen Virol 71 ( Pt 4), 977-81. 146. Sriwilaijaroen, N., Kondo, S., Yagi, H., Wilairat, P., Hiramatsu, H., Ito, M., Ito, Y., Kato, K., and Suzuki, Y. (2009). Analysis of N-glycans in embryonated chicken egg chorioallantoic and amniotic cells responsible for binding and adaptation of human and avian influenza viruses. Glycoconj J 26(4), 433-43. 147. Tiselius, A. (1937). Electrophoresis of serum globulin: Electrophoretic analysis of normal and immune sera. Biochem J 31(9), 1464-77. 148. Vakharia, V. N., Snyder, D. B., He, J., Edwards, G. H., Savage, P. K., and Mengel-Whereat, S. A. (1993). Infectious bursal disease virus structural proteins expressed in a baculovirus recombinant confer protection in chickens. J Gen Virol 74 ( Pt 6), 1201-6. 149. van den Berg, T. P., Morales, D., Eterradossi, N., Rivallan, G., Toquin, D., Raue, R., Zierenberg, K., Zhang, M. F., Zhu, Y. P., Wang, C. Q., Zheng, H. J., Wang, X., Chen, G. C., Lim, B. L., and Muller, H. (2004). Assessment of genetic, antigenic and pathotypic criteria for the characterization of IBDV strains. Avian Pathol 33(5), 470-6. 150. van Loon, A. A., de Haas, N., Zeyda, I., and Mundt, E. (2002). Alteration of amino acids in VP2 of very virulent infectious bursal disease virus results in tissue culture adaptation and attenuation in chickens. J Gen Virol 83(Pt 1), 121-9. 151. Virtanen, I., and Wartiovaara, J. (1974). Visualization of charged groups on the surface of rat liver nuclei. J Cell Sci 16(3), 665-75. 152. Wang, M. Y., Kuo, Y. Y., Lee, M. S., Doong, S. R., Ho, J. Y., and Lee, L. H. (2000). Self-assembly of the infectious bursal disease virus capsid protein, rVP2, expressed in insect cells and purification of immunogenic chimeric rVP2H particles by immobilized metal-ion affinity chromatography. Biotechnol Bioeng 67(1), 104-11. 153. Winterfield, R. W. (1969). Immunity response to the infectious bursal agent. Avian Dis 13(3), 548-57. 154. Winterfield, R. W., and Hitchner, S. B. (1962). Etiology of an infectious nephritis-nephrosis syndrome of chickens. Am J Vet Res 23, 1273-9. 155. Wintergerst, U., Hoffmann, F., Jansson, A., Notheis, G., Huss, K., Kurowski, M., and Burger, D. (2008). Antiviral efficacy, tolerability and pharmacokinetics of efavirenz in an unselected cohort of HIV-infected children. J Antimicrob Chemother 61(6), 1336-9. 156. Wu, P. C., Su, H. Y., Lee, L. H., Lin, D. T., Yen, P. C., and Liu, H. J. (2005). Secreted expression of the VP2 protein of very virulent infectious bursal disease virus in the methylotrophic yeast Pichia pastoris. J Virol Methods 123(2), 221-5. 157. Wu, Y., Hong, L., Ye, J., Huang, Z., and Zhou, J. (2009). The VP5 protein of infectious bursal disease virus promotes virion release from infected cells and is not involved in cell death. Arch Virol 154(12), 1873-82. 158. Wyeth, P. J., and Cullen, G. A. (1978). Susceptibility of chicks to infectious bursal disease (IBD) following vaccination of their parents with live IBD vaccine. Vet Rec 103(13), 281-2. 159. Wyeth, P. J., Gough, R. E., and Cullen, G. A. (1981). Immune responses of breeding chickens to trivalent oil emulsion vaccines: responses to Newcastle disease and infectious bursal disease. Vet Rec 108(4), 72-5. 160. Yamaguchi, T., Ogawa, M., Miyoshi, M., Inoshima, Y., Fukushi, H., and Hirai, K. (1997). Sequence and phylogenetic analyses of highly virulent infectious bursal disease virus. Arch Virol 142(7), 1441-58. 161. Yao, K., Goodwin, M. A., and Vakharia, V. N. (1998). Generation of a mutant infectious bursal disease virus that does not cause bursal lesions. J Virol 72(4), 2647-54.
摘要: 
傳統上蛋白質組成之分析,通常都是藉由高效能液相層析(HPLC),但是HPLC的動相溶劑常會被微粒分子阻礙,進而影響其再現性及解析度,且會產生大量的有機溶劑廢液。毛細管帶域電泳(Capillary zone electrophoresis,CZE) 是另一種有效的分析方法,分析樣品所需時間短,且兼顧效能的穩定性及準確性,而且只需要微量的樣品量即可進行分析。CZE是根據物質其荷質比之不同來進行分離,且最重要的是CZE可以使病毒保持在完整的顆粒下進行分析,並不會在操作過程中造成病毒顆粒的損壞。在CZE分離中最重要的就是其緩衝液和pH值,不同的緩衝液及酸鹼值所適用的對象皆不相同。CZE至今已經成功應用在許多病毒的分析研究上,包括菸草鑲嵌病毒、人類鼻病毒、重組腺病毒和輪狀病毒等等,但尚未有文獻提到使用CZE來分析傳染性華氏囊病病毒 (Infectious bursal disease virus,IBDV)。傳染性華氏囊病又稱作甘保羅病,由IBDV所引起,是一種具有高度傳染性的免疫抑制疾病,好發於年幼的雞隻,在全球家禽業已造成重大的經濟損失。完整的IBDV病毒顆粒和其免疫性具有高度相關性,並可誘導產生具保護性之免疫反應。因此,深入了解IBDV病毒顆粒之特性並將其應用在疫苗之製備,已成為當前重要之課題。本實驗之目的,是希望建立一個毛細管電泳分析系統,用來分析並檢測傳染性華氏囊病毒顆粒。首先,將經IBDV感染三天後之華氏囊和磷酸緩衝液混合,進行均質形成病毒原液。接著利用30 % 蔗糖進行初步的純化,緊接著進行氯化銫等密度梯度離心,完成病毒的分離與純化。純化之病毒經穿透式電子顯微鏡的觀察,以及反轉錄聚合

Traditional methods for the analysis of protein components, such as high performance liquid chromatograph (HPLC), are either time-consuming or inefficient. Instead, capillary zone electrophoresis(CZE)is a rapid, accurate and efficient technique used to separate mixtures of charged molecules/macromolecules. The most important feature of CZE is that intact shape of protein can be maintained during the operation. The separation occurs in a buffer solution where analytes separate and move according to their electrophoretic mobility past a detector. The CZE has been employed to study diverse viruses including tobacco mosaic virus, human rhinovirus, recombinant adenovirus and recombinant rotavirus etc, but no attempts have been made to analyze infectious bursal disease virus(IBDV). Infectious bursal disease(IBD)is a highly contagious and immunosuppressive disease caused by IBDV in young chickens. IBDV is responsible for major economic losses in the poultry industry worldwide. The integrity of IBDV particles is highly associated with its immunogenicity and the ability to induce protective immune responses. Therefore, characterization of IBDV particle is important to demonstrate a consistent vaccine manufacturing process. The purpose of this study is to setup a CZE to separate and identify IBDV particles prepared by sucrose and cesium chloride(CsCl) centrifugation from IBDV infected bursae. Bursae were collected from chickens infected with IBDV three days after challenge and homogenized in 1x PBS. IBDV were purified from bursal homogenate by ultracentrifugation with 30 % sucrose first and followed with CsCl solution. The purified IBDV were confirmed by transmission electron microscopy (TEM)and RT-PCR and applied into CZE with 1x PBS or BGE buffer (pH = 7 or 9) as running buffer using uncoated fused-silica capillaries. However, no peak was observed. A boric acid(pH = 9)running buffer was used and successfully form a single peak with electrophoretic mobility of 10 minutes indicating the IBDV particles. Furthermore, the single peak of IBDV particle was confirmed by binding IBDV with monoclonal anti-VP2 antibody and the virus-antibody complex was also analyzed by CZE. The signal of the previous peak of IBDV reduced and the virus-antibody complex formed an extra peak with electrophoretic mobility of 30 minutes. The results demonstrated that CZE is a capable method to separate and identify IBDV particles instead of time-consuming methods such as TEM and RT-PCR.
URI: http://hdl.handle.net/11455/66348
其他識別: U0005-1708201117051000
Appears in Collections:微生物暨公共衛生學研究所

Show full item record
 

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.